Glioma clinical trials in Indiana
4 studies for Glioma are looking for participants at sites in Indiana.
Cities in Indiana
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- Indiana University, Indianapolis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07703436SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Indiana University, Indianapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Riley Hospital for Children, Indianapolis
RecruitingPhase 1
Ages 1 to 25 · All sexes · Updated Aug 18, 2026 · NCT04485559Registering Genomics and Imaging of Tumors (ReGIT)
- Indiana University School of Medicine, Indianapolis
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2025 · NCT05386043From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.